Anti-inflammatory Therapy to Improve Outcomes After TPIAT

NCT02713997 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis, Chronic; Diabetes; Transplant

Interventions

DRUG: etanercept
DRUG: Alpha 1-Antitrypsin

Sponsor

University of Minnesota

Collaborators

[object Object]